Log in
Enquire now
Resolution Therapeutics

Resolution Therapeutics

Macrophage cell therapy developer for the treatment of inflammatory and fibrotic diseases.

OverviewStructured DataIssuesContributors

Contents

resolution-tx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Stem cell
Stem cell
Tissue engineering
Tissue engineering
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Immunotherapy
Immunotherapy
Biotechnology
Biotechnology
Cell therapy
Cell therapy
Location
United Kingdom
United Kingdom
Edinburgh
Edinburgh
CEO
‌
Amir Hefni
Founder
‌
John Campbell
‌
Stuart Forbes
Number of Employees (Ranges)
51 – 200
Email Address
contact@resolution-tx.com
Full Address
8 Bloomsbury St 2nd Floor London WC1B 3SR UK
5 Little France Drive Edinburgh EH16 4UU
Investors
Syncona Investment Management
Syncona Investment Management
Founded Date
2020
Total Funding Amount (USD)
83,300,000
Latest Funding Round Date
October 3, 2024
CFO
‌
Simon Ramsden
Latest Funding Type
Series B
Series B

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
83,300,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Resolution Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.